NL8006586A - N-adamanten-gesubstitueerde tetrapeptide-amiden. - Google Patents

N-adamanten-gesubstitueerde tetrapeptide-amiden. Download PDF

Info

Publication number
NL8006586A
NL8006586A NL8006586A NL8006586A NL8006586A NL 8006586 A NL8006586 A NL 8006586A NL 8006586 A NL8006586 A NL 8006586A NL 8006586 A NL8006586 A NL 8006586A NL 8006586 A NL8006586 A NL 8006586A
Authority
NL
Netherlands
Prior art keywords
formula
methyl
solution
amino
hydrogen
Prior art date
Application number
NL8006586A
Other languages
English (en)
Dutch (nl)
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of NL8006586A publication Critical patent/NL8006586A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8006586A 1979-12-03 1980-12-03 N-adamanten-gesubstitueerde tetrapeptide-amiden. NL8006586A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/099,765 US4273704A (en) 1979-12-03 1979-12-03 N-Adamantane-substituted tetrapeptide amides
US9976579 1979-12-03

Publications (1)

Publication Number Publication Date
NL8006586A true NL8006586A (nl) 1981-07-01

Family

ID=22276513

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8006586A NL8006586A (nl) 1979-12-03 1980-12-03 N-adamanten-gesubstitueerde tetrapeptide-amiden.

Country Status (16)

Country Link
US (1) US4273704A (es)
JP (1) JPS5692847A (es)
AU (1) AU6499080A (es)
BE (1) BE886472A (es)
CA (1) CA1151642A (es)
DE (1) DE3044793A1 (es)
DK (1) DK513480A (es)
ES (2) ES8205753A1 (es)
FR (1) FR2476073A1 (es)
GB (1) GB2066262B (es)
IT (1) IT1127930B (es)
NL (1) NL8006586A (es)
NO (1) NO803640L (es)
PT (1) PT72141B (es)
SE (1) SE8008428L (es)
ZA (1) ZA807513B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4404135A (en) * 1981-07-20 1983-09-13 G. D. Searle & Co. Enkephalin derivatives
US4407746A (en) * 1981-12-14 1983-10-04 G. D. Searle & Co. Cyclohexyl and phenyl substituted enkephalins
CS231221B1 (en) * 1982-06-29 1984-10-15 Martin Flegel L-alanyl-d-isoglutamine adamantylamide
US4629784A (en) * 1983-08-16 1986-12-16 The University Of Georgia Research Foundation, Inc. Synthesis of cyclopropane amino acids
DE3485587D1 (de) * 1983-08-16 1992-04-23 Univ Georgia Res Found Herstellung von aminocyclopropancarbonsaeuren und von peptiden.
US4510085A (en) * 1984-04-12 1985-04-09 G.D. Searle & Co. Antihypertensive tetrapeptide amides
US4514332A (en) * 1984-04-16 1985-04-30 G. D. Searle & Co. Tetrapeptide adamantyl amides
FR2572399B1 (fr) * 1984-10-31 1987-01-16 Panmedica Sa Nouveaux derives de l'adamantanamine, leurs procedes de preparation et medicaments les contenant
US4822775A (en) * 1986-02-14 1989-04-18 G. D. Searle & Co. Phenyl substituted dipeptide amides
US4880829A (en) * 1985-08-14 1989-11-14 G. D. Searle And Company Substituted dipeptide amides #3
US4758675A (en) * 1986-07-14 1988-07-19 G. D. Searle & Co. 3-thiophene-substituted tyrosyl dipeptide amides
US5652335A (en) * 1990-02-28 1997-07-29 Teikoku Seiyaku Kabushiki Kaisha Physiologically active substance well capable of permeating biomembrane
CA2076849A1 (en) * 1990-02-28 1991-08-29 Kouki Kitagawa Physiologically active substance well capable of permeating biomembrane
EP1574495A1 (en) 1997-01-14 2005-09-14 Daicel Chemical Industries, Ltd. Adamantane derivatives
US7795468B2 (en) * 2001-01-19 2010-09-14 Chevron U.S.A. Inc. Functionalized higher diamondoids
US7880001B2 (en) * 2004-04-29 2011-02-01 Abbott Laboratories Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
US8415354B2 (en) 2004-04-29 2013-04-09 Abbott Laboratories Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
US20050245534A1 (en) * 2004-04-29 2005-11-03 Link James T Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
US20050261302A1 (en) * 2004-04-29 2005-11-24 Hoff Ethan D Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their therapeutic application
US20100222316A1 (en) 2004-04-29 2010-09-02 Abbott Laboratories Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
US20080275112A1 (en) * 2004-07-23 2008-11-06 Schreiner Peter R Invention Concerning Aminoadamantane Compounds
CA2585735A1 (en) * 2004-11-02 2006-05-11 Pfizer Inc. Novel compounds of substituted and unsubstituted adamantyl amides
US20090192198A1 (en) 2005-01-05 2009-07-30 Abbott Laboratories Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
US8198331B2 (en) * 2005-01-05 2012-06-12 Abbott Laboratories Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
NZ555966A (en) * 2005-01-05 2011-03-31 Abbott Lab Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
HRP20050242B1 (en) * 2005-03-15 2010-09-30 Institut Ruđer Bošković Synthetic peptides containing unnatural adamantane related amino acids for use as antitumour drugs
JP5736098B2 (ja) 2007-08-21 2015-06-17 アッヴィ・インコーポレイテッド 中枢神経系障害を治療するための医薬組成物
EP2399926A1 (en) * 2010-06-22 2011-12-28 Justus-Liebig-Universität Giessen Peptides incorporating 3-aminoadamantane carboxylic acids enhance synaptic plasticity and act as neurogenic agents
CN112552374B (zh) * 2019-09-10 2024-06-04 西藏海思科制药有限公司 一种肽酰胺类化合物及其中间体的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2732451A1 (de) * 1976-07-27 1978-02-02 Reckitt & Colmann Prod Ltd Peptidverbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate

Also Published As

Publication number Publication date
JPS5692847A (en) 1981-07-27
IT8050294A0 (it) 1980-12-02
ES508060A0 (es) 1982-10-01
AU6499080A (en) 1981-06-11
NO803640L (no) 1981-06-04
FR2476073A1 (fr) 1981-08-21
ES8300087A1 (es) 1982-10-01
GB2066262A (en) 1981-07-08
ES497353A0 (es) 1982-06-16
ES8205753A1 (es) 1982-06-16
CA1151642A (en) 1983-08-09
US4273704A (en) 1981-06-16
IT1127930B (it) 1986-05-28
BE886472A (fr) 1981-06-03
DK513480A (da) 1981-07-09
ZA807513B (en) 1982-07-28
PT72141B (en) 1981-10-28
GB2066262B (en) 1983-05-11
PT72141A (en) 1981-01-01
SE8008428L (sv) 1981-06-04
DE3044793A1 (de) 1981-06-19

Similar Documents

Publication Publication Date Title
NL8006586A (nl) N-adamanten-gesubstitueerde tetrapeptide-amiden.
CA1258948A (en) Hydroxy substituted peptide compounds
US4259234A (en) Analgesic compounds
EP0618223A2 (en) Peptides inhibiting interleukin 1-bêta release useful as antiinflammatory agents
US4472305A (en) Hexapeptide amides
US4304715A (en) Enkephalin analogues
GB1592552A (en) Pseudopeptides used as medicaments
US4510082A (en) Pharmacologically active peptides
US4322340A (en) Pharmacologically active peptides
CA1156219A (en) Analgesic compounds
US4407746A (en) Cyclohexyl and phenyl substituted enkephalins
US4092304A (en) 4-Substituted enkephalin derivatives
DD200799A5 (de) Verfahren zur herstellung von peptiden
KR840001668B1 (ko) 펩티드의 제조방법
US4265808A (en) Pharmacologically active peptides
US4028319A (en) 2 and 3-substituted enkephalins
US4322342A (en) Analgesic compounds
Pitzele et al. Enkephalin analogs as systemically active antinociceptive agents: O-and N-alkylated derivatives of the dipeptide amide L-2, 6-dimethyltyrosyl-N-(3-phenylpropyl)-D-alaninamide
US4448717A (en) Pharmacologically active peptides
HU186375B (en) Process for the preparation of biologically active encephalina derivatives
DE3024313A1 (de) Tripeptidamide, verfahren zur herstellung derselben und diese enthaltende arzneimittel
CS199708B2 (en) Method of producing polypeptides and derivatives thereof having effect similar morphine
US4473497A (en) Pharmacologically active peptides
GB2065134A (en) Pharmacologically active peptides their preparation and pharmaceutical compositions containing them
GB1587427A (en) Polypeptide derivatives

Legal Events

Date Code Title Description
BV The patent application has lapsed